You just read:

Eiger Announces First Patient Dosed in Phase 2 Study of Pegylated Interferon Lambda in Hepatitis D Virus (HDV) Infection

News provided by

Eiger BioPharmaceuticals, Inc.

Oct 19, 2016, 08:00 ET